專(zhuān)利創(chuàng)新技術(shù)（專(zhuān)利號(hào)：ZL 201110087602.1）
結(jié)合HPV核酸分型定量分析軟件，同步21種HPV基因分型及定量（標(biāo)準(zhǔn)化定量）
60+國(guó)家及區(qū)域
全球化營(yíng)銷(xiāo)服務(wù)網(wǎng)絡(luò)
1000萬(wàn)+
碩世HPV產(chǎn)品已檢測(cè)超1000萬(wàn)人次
1.Zhengrong Sun , Rong Zhang , Zhonghua Liu, Chao Liu, Xiulin Li, Weiqiang Zhou, Lianxia Yang, Qiang Ruan and Xu Zhang. Development of a fluorescence–based multiplex genotyping method for simultaneous determination of human papillomavirus infections and viral loads. BMC Cancer (2015) 15:860. doi 10.1186/s12885-015-1874-9 Available at: https://pubmed.ncbi.nlm.nih.gov/26546160/
2.Dong B, Sun P, Ruan G, Huang W, Mao X, Kang Y, Pan D, Lin F. Type-specific high-risk human papillomavirus viral load as a viable triage indicator for high-grade squamous intraepithelial lesion: a nested case- control study. Cancer Manag Res. 2018 Oct 23;10:4839-4851. doi: 10.2147/CMAR.S179724. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205532/
3.Chen L, Dong B, Zhang Q, Mao X, Lin W, Ruan G, Kang Y, Sun P. HR-HPV viral load quality detection provide more accurate prediction for residual lesions after treatment: a prospective cohort study in patients with high-grade squamous lesions or worse. Med Oncol. 2020 Mar 30;37(5):37. doi: 10.1007/s12032-020-01363-z. Available at: https://link.springer.com/article/10.1007%2Fs12032-020-01363-z
4.Duan L, Du H, Wang C, Huang X, Qu X, Shi B, Liu Y, Zhang W, Duan X, Wei L, Belinson JL, Wu R. The application of BMRT-HPV viral load to secondary screening strategies for cervical cancer. PLoS One. 2020 May 1;15(5):e0232117. doi: 10.1371/journal.pone.0232117. Available at: https://pubmed.ncbi.nlm.nih.gov/32357165/
5.Tao X, Zhang H, Wang S, Chen T, Cong Q, Wang L, Zhou X, Zhao C. Prevalence and carcinogenic risk of high-risk human papillomavirus subtypes in different cervical cytology: a study of 124,251 cases from the largest academic center in China. J Am Soc Cytopathol. 2021 Jul-Aug;10(4):391-398. doi: 10.1016/j.jasc.2021.03.006. Available at: https://www.sciencedirect.com/science/article/abs/pii/S2213294521000417
6.Li Y, Gong YX, Wang Q, Gao S, Zhang H, Xie F, Cong Q, Chen L, Zhou Q, Hong Z, Qiu L, Li F, Xie Y, Sui L. Optimizing the Detection of Occult Cervical Cancer: A Prospective Multicentre Study in China. 27 October 2021 Volume 2021:13 Pages 1005—1015. doi: 10.2147/IJWH.S329129 Available at: https://www.dovepress.com/optimizing-the-detection-of-occult-cervical-cancer-a-prospective-multi-peer-reviewed-fulltext-article-IJWH
7.Yiying Wang, Yan Wang, Michael M. Gaisa, Keith Sigel, Wenxin Zheng , Yuxin Liu , Yue Wang. Negative Predictive Value of Human Papillomavirus Testing: Implications for Anal Cancer Screening in People Living with HIV/AIDS. Journal of Oncology. 22 January 2020 Volume 2020 https://doi.org/10.1155/2020/6352315 Available at: https://www.hindawi.com/journals/jo/2020/6352315/
8.Feng?et?al. Human papillomavirus prevalence and genotype distribution landscapes in Shannan City, Tibet Tibetan Autonomous Region, China. Virology Journal (2022) 19:46 2022 Mar 18;19(1):46.?doi: 10.1186/s12985-022-01775-5 Available at: https://virologyj.biomedcentral.com/articles/10.1186/s12985-022-01775-5
9.Xiang Tao, Huina Zhang, Hao Zhang, Yaoxing Xiao, Fangfang Zhong, Xianrong Zhou, Qing Cong, Long Sui, Chengquan Zhao. The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology A retrospective study of 8726 cases 2022 Mar 21.?doi: 10.1002/cncy.22573. Available at: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncy.22573
